COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20201004048923N1


Column Value
Trial registration number IRCT20201004048923N1
Full text link
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

ِDr Maliheh Paknejad

Contact
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

paknejadma@tums.ac.ir

Registration date
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2020-12-13

Recruitment status
Last imported at : Jan. 14, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Open label

Center
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Age between 20 to 60 years old Male sex COVID-19 patients with positive chest CT scan

Exclusion criteria
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Infectious diseases, cancer and autoimmune diseases Severe heart and liver diseases Existence of severe clinical symptoms that require hospitalization Diabetes

Number of arms
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Tehran University of Medical Sciences

Inclusion age min
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

20

Inclusion age max
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

60

Countries
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Moderate/severe/critical disease at enrollment

Severity scale
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

5: Moderate/severe/critical disease at enrollment

Total sample size
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

50

primary outcome
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Clinical symptoms improvement

Notes
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : Dec. 14, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 1729, "treatment_name": "Brewer's yeast+vitamin c", "treatment_type": "Nutrition+vitamins and dietary supplements", "pharmacological_treatment": "Non pharmacological treatment+pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]